No Data
Agilent Technologies, Inc.'s (NYSE:A) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
$100 Invested In Agilent Technologies 20 Years Ago Would Be Worth This Much Today
Trending Industry Today: Sangamo Therapeutics Leads Losses Pre-Market In Gene Editing Stocks
Agilent Technologies (NYSE:A) Jumps 5.8% This Week, Though Earnings Growth Is Still Tracking Behind Five-year Shareholder Returns
Express News | Agilent Technologies Receives FDA Approval For MAGE-A4 IHC 1F9 PharmDx As Diagnostic Tool To Identify Synovial Sarcoma Patients Eligible For TECELRA TCR T-Cell Therapy
Express News | Agilent Receives FDA Approval for Mage-a4 Ihc 1F9 Pharmdx as a Diagnostic Tool for Use With Newly Approved Tcr T-Cell Therapy